DIGITAL HEALTH INTELLIGENCE REPORT COLLECTION

How to harvest and share meaningful medical insights that inform strategy and support KOLs

The insights collected by MSLs play a critical role in shaping medical strategy and helping to build productive KOL relationships. But how can MSLs better filter information to extract actionable medical insights? Do in-person meetings really deliver better outcomes than digital interactions? Where can AI and machine learning contribute? What is the latest thinking on measuring the value of medical insights?

In Gathering and Disseminating Medical Insights: Improving MSL Practice, MSLs and MSL leaders reveal the latest strategies that will drive improvements in the collection and dissemination of powerful medical insights.

GET ACCESS TO THIS REPORT

Report Overview

Advanced medical wearables now comprise smart patches, smart rings, smart garments and smart ear buds and the emergence of validated medical-grade technology in consumer devices is seen as critical in delivering the next generation of wearables. Regulators are supportive and payers are seeing the contribution wearables can make to lowering the overall cost of health.

So, how can pharma benefit? In Innovations in Wearables for Digital Health digital health experts review the current wearables sector, examine the technologies that will shape the future and identify the challenges and areas of opportunity for pharma.

 Key Therapies Covered

Bavencio (avelumab)
 Keytruda (pembrolizumab) 
 Opdivo (nivolumab) 
 Tecentriq (atezolizumab) 

Imfinzi (durvalumab)
 Cabometyx (cabozantinib) 
 Fotivda (tivozanib) 
 Inlyta (axitinib) 

Lenvima/Kisplyx (lenvatinib)
 Sutent (sunitinib) 
 Votrient (pazopanib) 
 Afinitor (everolimus) 

 abexinostat 
 MK-6482 
 bempegaldesleukin 

CONTACT US FOR THE FULL LIST OF NAMED KOLS

Content Highlights

  • Subject synopsis
  • Research methodology and objectives
  • Key insights summary
  • Issues and insights
LEARN MORE

What Our Clients Are Saying

“Excellent”

Director, Medical Affairs, AstraZeneca

“...this report has been very valuable”

Director, Biotech New Product Planning and Drug Delivery, Eli Lilly

Contact Us

 Learn more about this report or how we can support you with additional insights. If you are already a client, log in to read the report.

© 2021 FirstWord. All rights reserved   |  1140 Avenue of the Americas, 14th Floor, New York, NY 10036

 Partial List of Participating KOLs

Deputy Director
Georgetown Lombardi Comprehensive Cancer Center, and the Scholl Professor and vice chair of the Department of Medical Oncology at Georgetown University Medical Center, Georgetown University School of Medicine, Washington, DC

Associate Professor of Oncology
Roswell Park Comprehensive Cancer Center, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY

Professor
Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Head of the Medical Oncology Department
Hospital Universitario Central de Asturias, Oviedo, Spain

Professor of Medicine
Head of the SS Genitourinary Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Professor of Oncology and Chief of the Oncology
Clinical and Translational Research Unit at Georges Pompidou Hospital, Paris, France

GET ACCESS TO THIS REPORT

Our Research

We engage the world’s leading key opinion leaders, ensuring the viewpoints delivered are authoritative and consequential. Strict screening criteria ensures high-quality interviews.

Our in-house senior analysts and medics leverage their disease area knowledge and market research expertise to identify the key questions and issues.

Our reports provide a detailed analysis, based on the candid views of world-renowned KOLs, of how treatment algorithms are likely to evolve over the next 3-5 years.

START NOW

 View A Full List Of Therapy Trends Reports

FirstWord ExpertViews reports reveal the real-world insights of knowledgeable experts to analyse in detail key commercial and market trends that pharma management needs to understand if they are to effectively respond to critical developments.

Leading KOLS

KOL Answers

Future Focused

What Makes FirstWord’s ExpertViews Reports Different?

Gathering and Disseminating Medical Insights: Improving MSL practice

MSL experts explore...

FIND THE ANSWERS

Expert Contributors

CONTACT US FOR FURTHER DETAILS ABOUT THE EXPERTS

Relevant to your needs

We don’t waste time telling you what you already know.  The tight screening of expert contributors ensures you get new, cutting edge and relevant insights to take your practical knowledge to new levels.

Boardroom ready

This ExpertViews report is supported by an engaging and accessible slide pack that summarises the core of the research and analysis, making key findings easy to share with colleagues and key stakeholders.

Fresh new content

Our reports cover the current developments and trends that will shape future markets and practice, helping you to identify threats and exploit opportunities.

Deep dive

Our research with industry experts results in hundreds of direct quotes, providing you with a first-hand, objective and comprehensive view of key market-shaping issues.

  • Paying for Value
  • Building on success of value-based approaches in health care
  • Drug VBCs are a priority for some payers
  • Choosing the right products
  • Manufacturer competence needed for VBC
  • Choosing the right payer to work with on a VBC
  • VBCs can be offered at launch
  • Technology is enabling VBCs
  • Piloting VBCs
  • Choosing the VBCs to publicize
  • The challenges in scaling up use of VBCs

Each issue addressed is broken down into the following subsections

  • Issue summary 
  • Questions
  • Key insights
  • Expert quotes
  • Intelligence exhibits

Content Highlights

LEARN MORE
  • Executive level experience in digital health, digital patient services or digital patient support with at least five years of involvement in digital health initiatives. 
  • At least three years’ experience in the field of digital health, mobile health, or digital capabilities for health.
  • Direct experience designing, executing or influencing innovations in wearables for digital health initiatives in the last 18 months.

Defining medical insights
Insights throughout the lifecycle
Ask about the right topics
Evolution in ways to gather medical insights
Medical insights are the responsibility of more than MSLs
Education can be combined with generating insights
Put in place a medical insights process
A role for artificial intelligence and machine learning
Sharing insights within the company
Metrics to measure insight gathering

  • How should the approach to gathering medical insights change across the different stages of the lifecycle: pre-launch, launch and post-launch?
  • Are opportunities for gathering insights from digital engagement activity changing as a result of phenomena such as webinar fatigue?
  • How can you optimise the generation of medical insights from social media?
  • What role can artificial intelligence and machine learning play in identifying medical insights from diverse sources?
  • How can you optimise the generation of actionable medical insights and disseminate such insights within the company?
  • How should metrics to measure medical insight gathering change in the light of COVID-19 driven changes to MSL working practice?
  • Joel Beilin, Founder and CEO of Global Audiology Consulting, Denmark
  • Giovanni Di Sarro, Senior Business Partner of Global Digital Solutions at Lundbeck, Denmark
  • Pierre-Alexandre Fournier, Co-founder of Hexoskin, a leading sensor and AI/analytics company for health, research and medicine
  • Serkan Oray, Vice President of Devices, Packaging, & Wearable Technologies at UCB, Belgium
  • Panos Papakonstantinou, Global Commercial Director of Mobility Solutions at the Novartis Institutes for BioMedical Research (NIBR), Switzerland
  • Gergely Vértes, Solution Accelerator Lead and the Wearable Clinical Project Lead in Epilepsy at UCB Bekgium
  • Dr. Jian Yang, Senior Director of Digital Health at Eli Lilly and Company, US
  • Anonymous, technology leader, multinational biopharmaceutical company

The experts who contributed to this report have been carefully screened to ensure they have direct and relevant subject area experience. Based on frontline knowledge, the actionable strategies these experienced MSLs and MSL leaders reveal are critical for driving improvements in the collection and dissemination of powerful medical insights.